Franklin Resources
INFI

Franklin Resources’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Franklin Resources’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-124,968
Closed -$26.3K – 2828
2023
Q2 		$26.3K Hold
124,968
– – ﹤0.01% 2653
2023
Q1 		$20K Hold
124,968
– – ﹤0.01% 2249
2022
Q4 		$69.4K Hold
124,968
– – ﹤0.01% 2174
2022
Q3 		$149K Buy
124,968
+47,977
+62% +$51.7K ﹤0.01% 2039
2022
Q2 		$49K Sell
76,991
-34,792
-31% -$26.7K ﹤0.01% 2245
2022
Q1 		$127K Hold
111,783
– – ﹤0.01% 2250
2021
Q4 		$252K Sell
111,783
-317
-0.3% -$796 ﹤0.01% 2155
2021
Q3 		$383K Buy
+112,100
New +$346K ﹤0.01% 1992
2014
Q3 		– Sell
-445,500
Closed -$5.68M – 1597
2014
Q2 		$5.68M Hold
445,500
– – ﹤0.01% 1162
2014
Q1 		$5.3M Buy
445,500
+10,300
+2% +$138K ﹤0.01% 1148
2013
Q4 		$6.01M Buy
435,200
+53,600
+14% +$757K ﹤0.01% 1103
2013
Q3 		$6.66M Buy
381,600
+91,500
+32% +$1.75M ﹤0.01% 1063
2013
Q2 		$4.71M Buy
+290,100
New +$8.98M ﹤0.01% 1095

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Franklin Resources's INFI Position: Q3 2023 in Review

Franklin Resources sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 124,968 shares — an estimated $26.3K sold.

Franklin Resources first reported a position in INFI in Q2 2013 and held it in 13 quarters. The position peaked at $6.66M in Q3 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Franklin Resources reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Franklin Resources sold 124,968 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $26.3K.
  • Franklin Resources first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
  • Franklin Resources's Infinity Pharmaceuticals, Inc. position peaked at $6.66M in Q3 2013.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Franklin Resources's 13F filing for Q3 2023, filed 13 Nov 2023.